THE Australian CRO for Biotechs

AVANCE Clinical

Full Service CRO

With strong co-existing relationships with all Phase 1 units across Australia.

Highly Experienced Team

Supporting our global client portfolio with over 20 years’ experience.

ROBUST DATA

World class reputation for accuracy, precision and quality data sets.

THE AUSTRALIAN Advantage

The Australian Regulatory Framework is the fastest in the world for undertaking early phase clinical trials.

About Avance Clinical

At Avance Clinical, we have over 20 years’ experience in offering seamless end-to-end in-house clinical research services, supporting our global client portfolio with clinical project management, trial monitoring, local safety reporting, medical writing, data management, statistical and pharmacokinetic services, CDISC and external and internal auditing.

As a leading Australian CRO, with extensive experience across all phases of clinical research, complemented with our full suite of in-house clinical research services, we can ensure your trials are delivered on time and on budget as a certified contract research organisation.

Avance Clinical Wins Frost & Sullivan “2020 Asia-Pacific CRO Market Leadership Award

Within Asia-Pacific’s highly competitive CRO market, Avance Clinical stands out as a leader in early phase biotech clinical trials.

The company offers a highly responsive and proactive service for biotechs wanting rapid and innovative clinical trial solutions, with the highest level of data compliance. Avance Clinical offers a real size match for biotechs that means better mission understandings and stronger customer service compared to some of the larger CROs.

Nidhi Jalali,
Analyst Best Practices, Frost & Sullivan

image left
image right
image left
image right

“We aim to give clients unparalleled service to optimise the timely and cost effective completion of projects. It’s as simple as that”

Yvonne Lungershausen,
Chief Executive Officer

“It has been a great pleasure working with you on this project. Your flexibility, pragmatic approaches and focus on the work has been exceptional. I am looking forward to have the next compound entering the clinic with you.”

Head of Drug Discovery
Pharmaxis Ltd

“Working with the Avance Team has helped us to develop and complete high quality and compliant clinical studies. I especially appreciate their penchant for communication, quality and pragmatism.”

– Sr. Vice President, Regulatory, Quality & Clinical Affairs
Atossa Genetics, Inc.

Latest News & Events

News | Avance Clinical Joins Medrio’s ‘Trial Talks’ Podcast about Why Clinical Trials are Thriving in Australia

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical, joins Medrio’s new podcast series Trial Talks. Trial Talks season 1, episode 1 “Why Clinical Trials are Thriving in Australia” focuses on how Avance Clinical prepared for the pandemic, what tools were leveraged that allowed trial continuation, and why clinical trials are currently thriving in the region.

News | Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa’s Second COVID-19 Therapeutic Development Program

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been contracted to conduct a clinical study of Atossa Therapeutics’ proprietary drug candidate AT-301, to be administered by nasal spray. Avance has successfully completed multiple clinical studies of Atossa’s proprietary Endoxifen.